Much Ilham Novalisa Aji Wibowo

Exploring of determinants factors of anti-diabetic medication adherence in several regions of asia – a systematic review

• Authors Details :  
• Much Ilham Novalisa Aji Wibowo,  
• Nanang Munif Yasin,  
• Susi Ari Kristina,  
• Yayi Suryo Prabandari

Journal title : Patient Preference and Adherence

Publisher : Informa UK Limited

Online ISSN : 1177-889X

Page Number : 197-215

Journal volume : Volume 16

442 Views Reviews Article

Background: The determinants of medication adherence in people with diabetes may differ between populations of an area due to social environment, cultural beliefs, socioeconomic conditions, education, and many other factors differences. Objective: Therefore, this study aims to explore, identify and classify the determinants of medication adherence in several Asian regions. Methods: A systematic literature review was conducted to gain insight into the determinants of medication adherence. Seven relevant databases (EBSCO, ProQuest, PubMed, ScienceDirect, Scopus, Wiley, dan Taylor, and Francis) and hand-searching methods were conducted from January 2011 to December 2020. Keywords were compiled based on the PICO method. The selection process used the PRISMA guidelines based on inclusion, and the quality was assessed using Crowe’s critical assessment tool. Textual summaries and a conceptual framework model of medication adherence were proposed to aid in the understanding of the factors influencing medication adherence. Results: Twenty-six articles from countries in several Asian regions were further analyzed. Most studies on type 2 diabetes patients in India used the MMAS-8 scale, and cross-sectional study is the most frequently used research design. The medication adherence rate among diabetic patients was low to moderate. Fifty-one specific factors identified were further categorized into twenty-three subdomains and six domains. Furthermore, the determinants were classified into four categories: inconsistent factors, positively related factors, negatively related factors, and non-associated factors. In most studies, patient-related factors dominate the association with medication adherence. This domain relates to patient-specific demographics, physiological feelings, knowledge, perceptions and beliefs, comorbidities, and other factors related to the patient. Several limitations in this review need to be considered for further research. Conclusion: Medication adherence to diabetic therapy is a complex phenomenon. Most determinants produced disparate findings in terms of statistical significance. The identified factors can serve various goals related to medication adherence. Policymakers and health care providers should consider patient-related factors.

Article DOI & Crossmark Data

DOI : https://doi.org/10.2147/PPA.S347079

Article Subject Details

• Clinical pharmacology
• Pharmacy
• Pharmacy practice
• Pharmacy practices
• Social pharmacy

Article Keywords Details

• Asia
• associated factors
• determinants
• diabetes mellitus
• patient-related factors
• Medication adherence

Article File

Full Text PDF

---

---

Article References

• (1). 10.1093/bmb/ldu018
• (2). 10.2478/s13382-014-0326-0
• (3). 10.1177/1010539513500336
• (4). 10.3389/fendo.2017.00006
• (5). 10.3389/fendo.2019.00056
• (6). 10.1186/1472-6963-12-270
• (7). 10.18553/jmcp.2016.22.3.305
• (8). 10.2337/dc11-1277
• (9). 10.1016/j.amjms.2016.01.010
• (10). 10.1111/dme.12651
• (11). 10.1016/j.diabres.2017.04.015
• (12). 10.1136/bmjopen-2017-016317
• (13). 10.1007/s40273-015-0268-9
• (14). 10.1136/bmjopen-2014-005992
• (15). 10.1016/j.diabres.2015.08.006
• (16). 10.2147/PPA.S212046
• (17). 10.1007/s11096-019-00933-0
• (18). 10.1371/journal.pmed.1003583
• (19). 10.1186/s13643-017-0644-y
• (20). 10.5195/JMLA.2018.345
• (21). 10.1002/14651858.MR000001.pub2
• (22). 10.1111/j.1744-1609.2011.00237.x
• (23). 10.1016/j.sapharm.2017.05.003
• (24). Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.
• (25). 10.3904/kjim.2016.195
• (26). 10.1016/j.dsx.2017.04.014
• (27). 10.1177/1010539513475651
• (28). 10.1007/s13410-014-0232-9
• (29). 10.24171/j.phrp.2018.9.4.05
• (30). 10.1016/j.cegh.2020.03.025
• (31). 10.7860/JCDR/2013/5352.2876
• (32). 10.4239/wjd.v9.i5.72
• (33). 10.3390/ijerph14121522
• (34). 10.2147/PPA.S105600
• (35). 10.3390/ijerph17176012
• (36). 10.1111/1753-0407.12238
• (37). 10.1080/10376178.2019.1583067
• (38). 10.1007/s11096-011-9582-2
• (39). 10.1016/j.dsx.2019.07.011
• (40). 10.2147/PPA.S81612
• (41). 10.1111/jcpt.12344
• (42). 10.1371/journal.pone.0225000
• (43). 10.1016/j.pcd.2015.09.004
• (44). 10.37268/mjphm/vol.21/no.2/art.1048
• (45). 10.1111/bcp.12194
• (46). 10.1007/s00592-020-01609-2
• (47). 10.1371/journal.pone.0223431
• (48). 10.1186/s13104-017-2454-7
• (49). 10.1177/0272684X19896724
• (50). 10.2337/diaclin.29.1.17
• (51). 10.2147/PPA.S86719
• (52). 10.1186/1471-2458-14-94
• (53). 10.7324/JAPS.2020.104007
• (54). 10.4103/jpbs.JPBS_257_19
• (55). 10.1007/s11096-014-9938-5
• (56). 10.4103/2230-8229.94008
• (57). 10.2337/cd016-0029
• (58). 10.1515/jbcpp-2019-0257
• (59). 10.2147/RMHP.S19801
• (60). 10.1111/j.1475-6773.2011.01250.x
• (61). 10.1007/s11606-012-2200-8
• (62). 10.1186/s12902-019-0360-9
• (63). 10.1186/s13643-019-1014-8
• (64). 10.2147/PPA.S192008
• (65). 10.1016/j.pcd.2014.03.001
• (66). 10.4236/ojepi.2017.73018
• (67). 10.1186/s13098-020-00567-7
• (68). 10.1186/s41043-019-0161-9
• (69). 10.1111/j.1751-7176.2008.07572.x
• (70). 10.1007/978-3-319-07794-9
• (71). 10.1177/1558689813495977
• (72). 10.1111/j.1524-4733.2005.04054.x
• (73). 10.4103/ijem.IJEM_579_17
• (74). 10.1111/j.1524-4733.2008.00400.x
• (75). 10.3389/fphar.2018.01124
• (76). 10.1016/j.pcd.2012.11.001

---

More Article by Much Ilham Novalisa Aji Wibowo